ArticleFrontiers in oncology2025
Comprehensive pan-cancer analysis and experimental validation reveal FCHSD1 as a potential biomarker for diagnosis, immune infiltration, and prognosis.
Ming Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.